126 related articles for article (PubMed ID: 1526657)
1. Mice are actively immunized after passive monoclonal antibody prophylaxis and ricin toxin challenge.
Lemley PV; Wright DC
Immunology; 1992 Jul; 76(3):511-3. PubMed ID: 1526657
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.
Kende M; Del Giudice G; Rivera N; Hewetson J
Vaccine; 2006 Mar; 24(12):2213-21. PubMed ID: 16325310
[TBL] [Abstract][Full Text] [Related]
3. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment.
Pratt TS; Pincus SH; Hale ML; Moreira AL; Roy CJ; Tchou-Wong KM
Exp Lung Res; 2007; 33(8-9):459-81. PubMed ID: 17994372
[TBL] [Abstract][Full Text] [Related]
5. Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MEL.
Mischak RP; Foxall C; Rosendorf LL; Knebel K; Scannon PJ; Spitler LE
Mol Biother; 1990 Jun; 2(2):104-9. PubMed ID: 2363853
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.
Kende M; Tan X; Wlazlowski C; Williams R; Lindsey C; Del Giudice G
Vaccine; 2007 Apr; 25(16):3219-27. PubMed ID: 17343960
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.
Durrant LG; Byers VS; Scannon PJ; Rodvien R; Grant K; Robins RA; Marksman RA; Baldwin RW
Clin Exp Immunol; 1989 Feb; 75(2):258-64. PubMed ID: 2784738
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
9. A mouse model for ricin poisoning and for evaluating protective effects of antiricin antibodies.
Beyer NH; Kogutowska E; Hansen JJ; Engelhart Illigen KE; Heegaard NH
Clin Toxicol (Phila); 2009 Mar; 47(3):219-25. PubMed ID: 19274499
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibody.
Hewetson JF; Rivera VR; Creasia DA; Lemley PV; Rippy MK; Poli MA
Vaccine; 1993; 11(7):743-6. PubMed ID: 8342322
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody prophylaxis against the in vivo toxicity of ricin in mice.
Chanh TC; Romanowski MJ; Hewetson JF
Immunol Invest; 1993 Feb; 22(1):63-72. PubMed ID: 8440524
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
Colombatti M; Johnson VG; Skopicki HA; Fendley B; Lewis MS; Youle RJ
J Immunol; 1987 May; 138(10):3339-44. PubMed ID: 2437188
[TBL] [Abstract][Full Text] [Related]
13. Passive immunization against murine malaria with an IgG3 monoclonal antibody.
Majarian WR; Daly TM; Weidanz WP; Long CA
J Immunol; 1984 Jun; 132(6):3131-7. PubMed ID: 6725950
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
15. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
16. Modulation of experimental autoimmune uveoretinitis by adoptive transfer of cells from rats immunized with anti-S-antigen monoclonal antibody.
de Kozak Y; Mirshahi M; Boucheix C; Faure JP
Reg Immunol; 1989; 2(5):311-20. PubMed ID: 2485681
[TBL] [Abstract][Full Text] [Related]
17. Production of polyclonal antibodies in mice against cobratoxin, botulinum toxin and ricin without altering their toxicity or use of adjuvant.
Lipps BV
J Nat Toxins; 2001 Feb; 10(1):27-32. PubMed ID: 11288726
[TBL] [Abstract][Full Text] [Related]
18. Protection against ricin intoxication in vivo by anti-idiotype vaccination.
Chanh TC; Hewetson JF
Vaccine; 1995 Apr; 13(5):479-85. PubMed ID: 7639015
[TBL] [Abstract][Full Text] [Related]
19. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
